The cytotoxic effects of indoleamine 2, 3-dioxygenase inhibitors on triple negative breast cancer cells upon tumor necrosis factor ? stimulation
dc.contributor.author | Bilir, C. | |
dc.contributor.author | Eskiler, G.G. | |
dc.contributor.author | Bilir, F. | |
dc.date.accessioned | 2024-05-19T14:33:14Z | |
dc.date.available | 2024-05-19T14:33:14Z | |
dc.date.issued | 2023 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description.abstract | Context: Overexpressed indoleamine 2,3-dioxygenase (IDO) has been observed in many types of cancer and plays an essential role in the tumor microenvironment through immune cells function. Aims: In our study, the therapeutic potentials of two different IDO inhibitors (Epacadostat [EPA] and 1-methyl-L-tryptophan [L-1MT]) in triple-negative breast cancer (TNBC) cells were assessed with and without tumor necrosis factor-? (TNF-?) stimulation. Materials and Methods: The anticancer activity of EPA and L-1MT alone and in combination with TNF-? was analyzed by WST-1, annexin V, cell cycle analysis, and acridine orange/ethidium bromide staining. In addition, the relationship between IDO1 and programmed death-ligand 1 (PD-L1) expressions in TNBC cells upon treatment with IDO inhibitors was evaluated by reverse transcription-polymerase chain reaction analysis. Statistical Analysis Used: SPSS 22.0 was conducted for statistical analysis. The one-way analysis of variance with Tukey's multiple comparison test was performed for multiple groups. Independent (unpaired) t -test was used for the comparison of two groups. Results: EPA and L-1MT alone significantly suppressed the TNBC cell viability through the induction of apoptotic cell death and G0/G1 arrest (P < 0.05). TNF-? alone induced the overexpression of IDO1 and PD-L1 in TNBC cells compared with MCF-10A control cells. However, IDO inhibitors significantly inhibited overexpressed IDO1 mRNA levels. Furthermore, EPA alone and co-treated with TNF-? suppressed the mRNA level of PD-L1 in TNBC cells. Therefore, TNF-? stimulation enhanced the therapeutic effects of IDO inhibitors on TNBC. Conclusions: Our findings showed that the efficacy of IDO inhibitors was mediated by pro-inflammatory cytokine. However, different molecular signaling pathways are associated with pro-inflammatory cytokines production, and the expression of IDO1 and PD-L1 calls for further investigations. © 2022 Journal of Cancer Research and Therapeutics | Published by Wolters Kluwer - Medknow. | en_US |
dc.identifier.doi | 10.4103/jcrt.jcrt_2365_21 | |
dc.identifier.endpage | 80 | en_US |
dc.identifier.issn | 0973-1482 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 37147986 | en_US |
dc.identifier.scopus | 2-s2.0-85159113341 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 74 | en_US |
dc.identifier.uri | https://doi.org/10.4103/jcrt.jcrt_2365_21 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/4151 | |
dc.identifier.volume | 19 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer Medknow Publications | en_US |
dc.relation.ispartof | Journal of Cancer Research and Therapeutics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | 20240519_ka | en_US |
dc.subject | 3-Dioxygenase | en_US |
dc.subject | 3-Dioxygenase İnhibitors | en_US |
dc.subject | Epacadostat | en_US |
dc.subject | İndoleamine 2 | en_US |
dc.subject | İndoleamine 2 | en_US |
dc.subject | Triple-Negative Breast Cancer | en_US |
dc.subject | Tumor Necrosis Factor-? | en_US |
dc.title | The cytotoxic effects of indoleamine 2, 3-dioxygenase inhibitors on triple negative breast cancer cells upon tumor necrosis factor ? stimulation | en_US |
dc.type | Article | en_US |